Abstract
The blood-brain barrier is the structure that maintains central nervous system homeostasis; it is composed of brain endothelial cells, astroglia, pericytes, microglia, and of the extracellular matrix components basal lamina and glycocalyx. The blood-brain barrier constitutes the main interface between the brain and the periphery; therefore it is the main structure regulating the passage of molecules from blood-to-brain and vice versa. At brain endothelial cells are expressed numerous members of the solute carrier (SLC) and ATP-binding cassette (ABC) gene families; those carriers exert selective transport and preclude free exchange of molecules from blood-to-brain. In addition, brain endothelial cells present low paracellular diffusion and vesicle-mediated transport. The regulation of the blood-brain barrier permeability is essential to guarantee nutrient supply to brain cells, but also to allow selective passage of drugs designed to treat brain diseases. This review describes both the pharmacological and physiological approaches to modulate the permeability of the blood-brain barrier. Finally we propose that once more data on blood-brain barrier normal physiology are obtained, health professionals will be able to take advantage of normal variations in blood-brain barrier permeability to administer drugs aimed to affect the central nervous system in the critical time window of blood-brain barrier “opening”.
Keywords: blood-brain barrier permeability, brain endothelial cells, caveolae, receptor-mediated endocytosis, carrier systems, tight junctions, Beta-catenin, homotypically, paracellular leukocyte, lipophilic, neovascularization, abluminal, Plasminogen, diencephalon, dementia.
Current Psychopharmacology
Title:From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier
Volume: 1
Author(s): B. Gomez-Gonzalez, K. Sanchez-Alegria and J. Velazquez-Moctezuma
Affiliation:
Keywords: blood-brain barrier permeability, brain endothelial cells, caveolae, receptor-mediated endocytosis, carrier systems, tight junctions, Beta-catenin, homotypically, paracellular leukocyte, lipophilic, neovascularization, abluminal, Plasminogen, diencephalon, dementia.
Abstract: The blood-brain barrier is the structure that maintains central nervous system homeostasis; it is composed of brain endothelial cells, astroglia, pericytes, microglia, and of the extracellular matrix components basal lamina and glycocalyx. The blood-brain barrier constitutes the main interface between the brain and the periphery; therefore it is the main structure regulating the passage of molecules from blood-to-brain and vice versa. At brain endothelial cells are expressed numerous members of the solute carrier (SLC) and ATP-binding cassette (ABC) gene families; those carriers exert selective transport and preclude free exchange of molecules from blood-to-brain. In addition, brain endothelial cells present low paracellular diffusion and vesicle-mediated transport. The regulation of the blood-brain barrier permeability is essential to guarantee nutrient supply to brain cells, but also to allow selective passage of drugs designed to treat brain diseases. This review describes both the pharmacological and physiological approaches to modulate the permeability of the blood-brain barrier. Finally we propose that once more data on blood-brain barrier normal physiology are obtained, health professionals will be able to take advantage of normal variations in blood-brain barrier permeability to administer drugs aimed to affect the central nervous system in the critical time window of blood-brain barrier “opening”.
Export Options
About this article
Cite this article as:
Gomez-Gonzalez B., Sanchez-Alegria K. and Velazquez-Moctezuma J., From Blood-to-Brain: Regulating the Permeability of the Blood-Brain Barrier, Current Psychopharmacology 2012; 1 (3) . https://dx.doi.org/10.2174/2211556011201030214
DOI https://dx.doi.org/10.2174/2211556011201030214 |
Print ISSN 2211-5560 |
Publisher Name Bentham Science Publisher |
Online ISSN 2211-5579 |
Call for Papers in Thematic Issues
Breakthroughs in drug design, development and delivery system for the management of neuro-psychiatric disorders
Neuropsychiatric diseases are one of the main causes of disability, affecting millions of people. Various drugs are used for its treatment, although no effective therapy has been found yet. The blood brain barrier (BBB) significantly complicates drugs delivery to the target cells in the brain tissues. This proposal describes the ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
Current Pharmaceutical Design Monoamine Oxidase-B (MAO-B) Inhibitors in the Treatment of Alzheimer’s and Parkinson’s Disease
Current Medicinal Chemistry Synthesis of Functionalized Chromenes from Meldrum’s Acid, 4- Hydroxycoumarin, and Ketones or Aldehydes
Combinatorial Chemistry & High Throughput Screening Allocentric to Egocentric Spatial Switching: Impairment in aMCI and Alzheimer's Disease Patients?
Current Alzheimer Research Elucidating Treatment of Alzheimer's Disease via Different Receptors
Current Topics in Medicinal Chemistry Nuclear Imaging of Post-infarction Inflammation in Ischemic Cardiac Diseases - New Radiotracers for Potential Clinical Applications
Current Radiopharmaceuticals Potential Biomarkers for Depression Associated with Coronary Artery Disease: A Critical Review
Current Molecular Medicine Aluminum Vaccine Adjuvants: Are they Safe?
Current Medicinal Chemistry The Efficacy and Safety of Pharmacological Treatments for Post-stroke Aphasia
CNS & Neurological Disorders - Drug Targets Imidazoline Receptor Agonists for Managing Hypertension May Hold Promise for Treatment of Intracerebral Hemorrhage
Current Molecular Medicine Alzheimer's Disease: Emerging Trends in Small Molecule Therapies
Current Medicinal Chemistry Comparison of Mono-dopaminergic and Multi-target Pharmacotherapies in Primary Parkinson Syndrome and Assessment Tools to Evaluate Motor and Non-motor Symptoms
Current Drug Therapy The Updated Role of the Blood Brain Barrier in Subarachnoid Hemorrhage: From Basic and Clinical Studies
Current Neuropharmacology Therapeutic Hypothermia in Brain Injuries and Related Diseases
Recent Patents on Inflammation & Allergy Drug Discovery Relevance of Nutritional Antioxidants in Metabolic Syndrome, Ageing and Cancer: Potential for Therapeutic Targeting
Infectious Disorders - Drug Targets Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective
Current Alzheimer Research Intracellular Amyloid β-Protein and Its Associated Molecules in the Pathogenesis of Alzheimers Disease
Mini-Reviews in Medicinal Chemistry Molecular Biomarkers in Schizophrenia – Implications for Clinical Practice
Current Psychiatry Reviews New Molecular Avenues in Parkinson ’ s Disease Therapy
Current Topics in Medicinal Chemistry In Vitro Models of the Blood-Brain Barrier: When to Use Which?
Current Medicinal Chemistry - Central Nervous System Agents